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1. Introduction 
For thousands of years mankind has used the resources of flora in the treatment of various 
diseases. There are reports, for example, of the use of plants for therapeutic purposes dating 
back to 3000 BC in the Chinese work Pen Ts'ao by Shen Nung (Tyler, 1996; Ko, 1999). In 78 
AD, the Greek botanist Pedanios Dioscorides described about 600 medicinal plants and this 
treaty remained as a reference source for more than fourteen centuries (Robbers et al., 1996; 
Tyler, 1996). The therapeutic properties of certain plants were discovered and propagated 
from generation to generation as a part of the popular culture through observation and 
experimentation by primitive people (Turolla & Nascimento, 2006). 
In the sixteenth century, the Swiss physician Philippus Aureolus Theophrastus Bombastus 
von Hohenheim, known as Paracelsus (1493 - 1541), formulated the "Theory of Signatures" 
based on the latin proverb similia similibus curantur, which means "alike cures alike". 
According to this theory it was believed that the shape, color, flavor and odor of the plants 
were related to their therapeutical properties, giving clues to their clinical use. Some of these 
plants have become part of the allopathic and homeopathic pharmacopoeias since the 
nineteenth century, when their therapeutic basis started to be investigated (Elvin-Lewis, 
2001). The isolation of morphine from Papaver somniferum in 1803 by the pharmacist 
Friedrich Wilhelm Adam Sertürmer marked the beginning of the extraction process of active 
ingredients from plants. Since then, other substances have been isolated, such as quinine 
and quinidine obtained from Cinchona sp in 1819, and atropine from Atropa belladonna, in 
1831, which started to be used instead of plant extracts (Tyler 1996; Schulz, 2001).  
The production of drugs by chemical synthesis, the growing of the economic power of 
pharmaceutical industries and the lack of scientific evidence on the efficacy of substances 
from plant origin combined with the difficulty of chemical, physico-chemical, pharmacological 
and toxicological control of plant extracts used so far, boosted their replacement by synthetic 
drugs (Rates, 2001). After the 1960s, there was a lack of interest from pharmaceutical 
companies and research institutes in the search for new substances from plant origin. This 
fact was due to the belief that the main active ingredients from known herbal drugs had 
already been isolated and all possible chemical modifications in these substances had 
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already been performed (Schenkel et al., 2000). However, since the 1980s, technical advances 
and the development of new methods for isolation of active compounds from natural 
sources have enabled faster identification of substances in complex samples such as plant 
extracts. And so, there was a resurgence of interest in the research of these substances as 
prototypes for the development of new drugs from medicinal plants. According to Carvalho 
(2004), these medicinal plants are the ones which are selected and popularly used as 
medicine in treating diseases. They are defined by World Health Organization (WHO) 1978, 
as being any plant, which applied in a particular form and by any means to the human 
being, is capable of causing a pharmacological effect. 
So, even after the development of large pharmaceutical laboratories and synthetic drugs, 
medicinal plants remained as an alternative form of treatment in various parts of the world. 
In the last decades, a revaluation of the use of herbal preparations was observed. These 
preparations are defined as any medication obtained and prepared, using only vegetable 
raw material with prophylactic, curative or diagnostic purposes, causing benefit to the user 
(Carvalho, 2004). Thus, some pharmaceutical companies began to make efforts toward the 
improvement of herbal medicines and their production on an industrial scale. This new 
development of herbal medicines, far from returning to the past, is characterized by the 
pursuit of industrial scale production, differently from the handmade forms which 
characterized its early stages (Turolla & Nascimento, 2006). 
Currently, preparations derived from medicinal plants are widely used in many countries. 
In Africa, for example, 80% of the population depends on the use of these preparations, 
which represent alternatives to the high costs of synthetic drugs (Turolla & Nascimento, 
2006). 
The consumption of medicinal plants and herbal products has been somewhat surprising in 
recent years, constituting a promising pharmaceutical segment. This fact is primarily noted 
as a result of easy access, low cost and its popular or cultural compatibility (Tyler, 1996). 
Medicinal plants are an important source of substances with biological activities. Many of 
them have become prototypes for the synthesis of a large number of bioactive compounds. 
Research indicates that Brazil is the world leader in plant diversity with about 55,000 
described species and 350,000 to 550,000 estimated ones. From the cataloged ones, 10,000 
species can be medicinal, aromatic or have other utilities (Borges et al., 2003). 
Therefore there’s a need to combine empirical knowledge about the popular use of 
medicinal plants with scientific research based on detailed studies of the plant species, as 
well as botanical, phytochemical, pharmacological, toxicological aspects, and the 
development of scientific and technological methodologies (Petrovick et al., 1997). The result 
of this scientific breakthrough is the development of a differential therapeutic herbal 
product, as unlike the traditional preparations obtained from plants in folk medicine, the 
scientific and technological grounding provide the development of herbal medicine 
(Wagner & Wiesenau, 2006; Leite, 2008). 
So, the plant species that will be used in the development of phytotherapeutics deserves 
cares in its acquisition, like a previous unequivocal botanical identification, as popular 
names of the plants are very often regional, varying according to the region where they 
grow, so, it is very common that the same plant species has different vernacular 
denominations. On the other hand, different botanical species may have the same vernacular 
denomination, Furthermore, for a few different species, with some morphological similarity, 
the unequivocal distinction between them becomes very difficult; being not rare the cases of 
poisoning due to incorrect identification of the plant species (Farias,1985; Mengue, 2001). 
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Therefore it is indispensable the standardization of the starting material and intermediates 
in order to assure the quality of the product derived from them. 
Standardization of material derived from plants represents a major challenge, especially for 
reproduction of biological effects. Botanical derivatives, when used for therapeutic purpose, 
are more complicated concerning the requirements of composition, constancy, stability, 
microbiological counts, etc. (Yunes et al., 2001). 
The chemical standardization of derivatives of medicinal plants, like extracts and fractions, 
demands the application of methods and techniques that aim at detecting and characterizing 
substances that guarantee the quality of the plant material used, either by the aspect of the 
metabolic composition, chemical marker; or by the pharmacological activity, substances 
related to the activity of the plant, able to be quantified. However, studies prove that the 
plant secondary metabolism can vary considerably according to air temperature, water 
availability, ultraviolet radiation, nutrients, soil altitude and air quality in the place where 
the vegetable grows. Even mechanical stimulations or pathogens’ attack can induce such 
variability, leading to the seasonal production of those potential markers (Gobbo-Neto, 
2007). 
The method used in the standardization of the starting material and derivatives must be 
validated considering the following parameters: specificity/selectivity, linearity, interval, 
precision, limit of detention, limit of quantification, accuracy and robustness, which must be 
determined and verified (Brazil, 2003). 
The concern of regulatory agents about the standardization of herbal medicines provides the 
evaluation of important aspects such as efficacy and safety of these medications. The 
traditional use of various medicinal herbs based on folk knowledge and the belief that, 
being natural does not provoke adverse reactions, caused just a few of them to be evaluated 
through preclinical and clinical studies to prove their efficacy and safety (Turolla et al., 
2006). 
Vegetable raw material such as plants, pharmacogens or derivatives (extracts, tinctures, 
essential oils or dried products) has been widely used in drugstores and pharmaceutical 
industries. What worries most the scientific community is the use of new plant species as 
medicines without proven data about their biological action, non-toxicity (assessed in 
humans), side effects, safety, efficacy and others. Although these herbal medicines have 
natural active constituents, they should be assessed as drugs and therefore subjected to strict 
controls at every stage of their idealization, evaluation and development. 
2. Definitions 
2.1 Phytotherapy (Gaedcke & Steinhoff, 2003) 
The term “phytotherapy” means the “prevention and treatment of human diseases using 
plants, parts of plants or preparations of plants”.  
The phytotherapy is a form of medicine that has grown noticeably over the years to the 
point that currently the world market for herbal medicines is around 44 billion dollars. 
For Weiss and Fintelmann, it is a decisive aspect that the plant or parts of a plant which are 
used for pharmaceutical purposes are regarded as an active substance as a whole. Herbal 
medicinal products, in this regard, are always mixtures of a number of substances. 
Phytotherapy has to be distinguished from other acknowledged therapeutic disciplines 
which also utilize plants such as homeopathy, invented by Samuel Hahnemann, and 
anthroposophy, whose background is on the Rudolf Steiner philosophy. The main difference 
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is that homeopathy is based on the principle “similia similibus curentur” – similar 
symptoms are healed by similar medicines. Besides that, homeopathy mostly uses very low 
doses. Efficacy is increased with the degree of dilution (potentiation). 
Similar to homeopathy, anthroposophic medicine is based on a global approach to diseases. 
It focuses on the strong connection between human being and nature. Besides that, 
anthroposophy takes into account cosmological aspects when selecting the right medicine 
for individual cases of illness. In the same way as homeopathic medicines, anthroposophic 
medicines are mostly obtained from natural origin. They are partly manufactured according 
to the principles of homeopathy, sometimes also using heat (e. g. roasting, carbonization). 
In contrast to homeopathy and anthroposophy, phytotherapy should definitely be 
understood as an allopathic discipline because the effects which are expected from herbal 
medicinal products are directed against the causes and the symptoms of a disease. Because 
of these important differences, phytoteraphy, in contrast to actual interpretation, in 
Germany for example, should not belong to the so-called “special therapeutic disciplines” or 
to “alternative medicine”. It should, moreover, be classified as a regular discipline of natural 
orthodox science-oriented medicine, because the respective medicinal products have to 
comply with the same scientific requirements as those of the chemically defined substances 
in terms of quality, safety and efficacy. 
2.2 Herbal drugs 
For the term “herbal drug”, the following definitions can be found in literature: 
Drugs are herbal or animal organisms or organs transformed into a storable condition by 
drying. Furthermore, the definition comprises other matter extracted from plants or animals 
without organic structure such as resins, gums, fats, essential oils (Gaedcke & Steinhoff, 
2003). 
Drugs are complex active substances which are either used by patients as original herbal 
drugs or which serve as industrial starting materials for the manufacture of finished 
medicinal products or for the isolation of purified active substances or mixtures of 
substances. Drugs are either organized on a cellular basis, i. e. microorganisms, plants, 
animals or parts of these which have been dried or submitted to otherwise preservation or 
they are mixtures of substances which have been extracted from microorganisms, plants, 
animals or parts of these which do no longer have cellular structures, such as essential oils, 
resins, starch, fats, waxes, isolated mucous substances or animal toxins (Teuscher, 1997). 
Herbal drugs are plants or parts of plants which have been transformed into storable 
conditions by drying, such as herba-, folium-, flos-, semen-, and radix drug (Hãnsel, 1991). 
According to pharmaceutical linguistic rules, herbal drugs are dried or processed plants or 
parts of plants used for the manufacture of pharmaceutical preparations (Saller et al., 1995). 
According to pharmaceutical linguistic rules, herbal drugs are dried herbal or animal 
starting materials (Bauer et al., 2002).  
Herbal drugs are herbal matter used for pharmaceutical purposes. A “herbal drug” or a 
produced preparation therefore, is regarded as one active substance irrespective of the 
question of whether the active constituents of the herbal drug are known or not (Gaedcke & 
Steinhoff, 2003). 
The definition for herbal drug in the European Pharmacopoeia is mainly whole, fragmented 
or cut, plants, parts of plants, algae, fungi, lichen in an unprocessed state, usually in a dried 
form, but sometimes fresh. Certain exudates that have not been subjected to a specific 
treatment are also considered to be herbal drugs. Herbal drugs are precisely defined by a 
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botanical scientific name according to the binomial system (genus, species, variety and 
author). 
According to the definition of the European Pharmacopoeia, the expression “herbal drug” 
shall apply to herbal materials in dried as well as in fresh conditions, which from a specific 
point of view makes no sense. As a consequence, two kinds of herbal drugs would have to 
be distinguished, frist, the so-called “fresh herbal drug”, which is a contradiction in itself 
(oxymoron) because the term “drug” implies that a material has been submitted to some 
kind of drying process, and second the so-called “dried herbal drugs” which due to the 
same reason, is linguistic nonsense. 
Therefore, the starting materials used for the manufacture of herbal medicinal products 
should preferably be named “herbal drug” or “fresh part of plant”. 
2.3 Herbal medicinal products 
Herbal medicinal products (Phytopharmaka) are regarding the active substance(s), more or 
less enriched preparations of plants or herbal drugs which, besides that, contain other 
concomitant substances exerting or not exerting therapeutic activity (Vogel, 1982). 
Herbal medicinal products (Phytopharmaka) are those medicinal products which, as active 
substances, solely contain herbal drug preparations, such as comminuted parts of plants, 
extracts, pressed juices or distillates of plants. Isolated plant constituents such as digitoxin or 
menthol, as well as homeopathic medicinal products, are not regarded as herbal medicinal 
products. 
Herbal medicinal products (Phytopharmaka) are complex preparations of herbal origin, i.e. 
galenic preparations of plants used within the sense of allopathic therapy. Isolated biogenic 
pure substances and complex preparations obtained from plants intended for use within 
alternative therapies such as homeopathy or anthroposophy do not fall within this 
definition (Teuscher, 1997).  
2.4 Herbal drug preparations 
According to the definition given in the European Pharmacopoeia Supplement 2000, herbal 
drug preparations are obtained by subjecting herbal drug to treatments such as extraction, 
distillation, expression, fractionation, purification, concentration and fermentation. These 
include comminuted or powdered herbal drug, tinctures, extracts, essential oils, fatty oils, 
expressed juice and processed exudates.  
Extracts obtained from herbal drugs comply with the monograph on Extracts. Tinctures 
obtained from herbal drugs comply with the monograph on Tinctures. 
Herbal teas comply with the monograph on Herbal teas. 
Instant herbal teas consist of powder or granules of one or more herbal drug preparation(s) 
intended for the preparation of an oral solution immediately before use. 
Extracts are preparations of liquid (liquid extracts and tinctures), semi-solid (soft extracts) or 
solid (dry extracts) consistency, obtained from herbal drugs or animal matter usually in a 
dry state. 
Different types of extracts may be distinguished. Standardized extracts are adjusted within 
an acceptable tolerance to a given content of constituents with known therapeutic activity; 
Standardization is achieved by adjustment of the extract with inert material or by blending 
batches of extracts. Quantified extracts are adjusted to a defined range of constituents; 
adjustments are made by blending batches of extracts. Other extracts are essentially defined 
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by the production process (state of the herbal drug or animal matter to be extracted, solvent, 
extraction conditions) and their specifications. 
Soft extracts are semi-solid preparations obtained by evaporation or partial evaporation of 
the solvent used for preparation. 
Dry extracts are solid preparations obtained by evaporation of the solvent used for their 
production. Dry extracts usually have a loss on drying or water content not greater than 5 
per cent m/m. 
Liquid extracts are liquid preparations of which, in general, 1 part by mass or volume is 
equivalent to 1 part by mass of the herbal drug or animal matter. These preparations are 
adjusted, if necessary, so that they satisfy the requirements for the content of the solvent 
and, where applicable, for the constituents. 
Tinctures are liquid preparations which are usually obtained using either 1 part of herbal 
drug or animal matter and 10 parts of extraction solvent or 1 part of herbal drug or animal 
matter and 5 parts of extraction solvent.  
Different types of extracts may be distinguished. Standardized extracts are adjusted within 
an acceptable tolerance to a given content of constituents with known therapeutic activity; 
Standardization is achieved by adjustment of the extract with inert material or by blending 
batches of extracts. Quantified extracts are adjusted to a defined range of constituents; 
adjustments ar made by blending batches of extracts. Other extracts are essentially defined 
by the production process (state of the herbal drug or animal matter to be extracted, solvent, 
extraction conditions) and their specifications (Gaedcke & Steinhoff, 2003). 
2.5 Classification of extracts in terms of their physical state 
Depending on the physical state of an extract the following types can be distinguished: 
- Liquid preparation: liquid extracts (fluid extract, tincture), oily macerates, 
- Semi-solid preparations: soft extracts,  
- Dry extracts: dry extracts. 
The difference between fluid extract and tincture is that tinctures are not concentrated but 
diluted preparations.  
The comminuted, mostly dried parts of the plant and the extraction solvent are combined in 
the extractor. This mixture is allowed to stand for several hours depending on the extraction 
process. Generally, extraction with additional extraction solvent is repeated until no more 
constituents are transferred to the extraction solution. In the next step, the extraction 
solution (miscella, eluate) is separated from the herbal drug residue. Since it contains the 
extractable herbal matter, the eluate represents an important intermediate product during 
the total manufacturing process. 
If the extraction solvent is ethanol or water or a mixture of both, the preparations resulting 
after filtration are liquid extracts (fluid or tincture, depending on the grade of 
concentration). If the extraction is carried out with vegetable oils (e. g. rape oil or olive oil) 
oily macerates are obtained which are usually filled in soft gelatin capsules. 
If the resulting preparation is a dry extract, processing of the eluate continues with cautious 
evaporation of the majority of the extraction solvent in the vacuum-evaporator. The 
resulting aqueous soft extract is evaporated to dryness using suitable drying aggregates, e. 
g. spray dryer, belt dryer or spray belt dryer. In most cases, suitable technical excipients 
such as maltodextrin, lactose or silicium dioxide have to be added. After grinding and 
sieving, flowable powder is obtained which can be further processed to tablets or coated 
tablets or filled in soft or hard gelatin capsules (Gaedcke & Steinhoff, 2003). 
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2.6 Ratio of the herbal drug to the extraction solvent 
Maceration (extraction under steady-state conditions) 
In this procedure, the ratio of the herbal drug to the extraction solvent is a decisive factor for 
the effectiveness (= extent) of the extraction. The quantity of extractable matter is increased 
with the quantity (mass, volume) of extraction solvent, as using higher amounts of 
extraction solvent, steady-state conditions are reached later. 
The ratio of the herbal drug to the extraction solvent is, therefore, a relevant parameter for 
the quality of the extract and has to be exactly defined to ensure batch-to-batch conformity. 
It has to be specified as a fixed ratio, e.g. of 1:5 or 1:10. 
Percolation (= exhaustive extraction) 
In this extraction procedure, a fixed quantity of herbal drug (mass) is treated with a variable 
quantity (mass/volume) of extraction solvent until the extractable matter is completely 
transferred from the herbal drug matrix to the eluate (percolate). The ratio of the herbal 
drug to the extraction solvent may therefore vary from batch to batch within a certain range. 
It depends on the characteristics of the herbal drug (content of extractable matter, loss on 
drying, etc.). Herbal drug preparations manufactured by percolation procedures are 
described by the average quantity (mass/volume) of extraction solvent with a defined 
range, e.g. 1:12 (1:10 to 1:14). 
This means that in case of tinctures the relevant factor for the quality of the preparation is 
the ratio of the herbal drug to the extraction solvent, and not the ratio of the herbal drug to 
the final tincture which is determined after the expression of the extraction solvent. 
Depending on the effectiveness of the expression process, the resulting ratio can be as 
follows: 
- For tinctures 1:10 – a ratio of the herbal drug to the tincture of 1:7 to 1:9, 
- For tinctures 1:5 - a ratio of the herbal drug to the tincture of 1:4 to 1:4, 5. 
Subsequent filling-up to the initial ratio of the herbal drug to the extraction solvent of 1:10 or 
1:5 is not in compliance with pharmacopoeial standards unless it is necessary for the 
adjustment of the preparation to a defined content of constituents or a group of constituents 
with known therapeutic activity (Gaedcke & Steinhoff, 2003). 
3. Harvest and postharvest processing 
Botanic is an essential area in the study of medicinal plants, which constitutes a very 
heterogeneous set of plants distributed in different taxonomic groups, with very different 
morpho-anatomic characteristics and whose unifying factor is their richness of 
pharmacologically active compounds. As a considerable proportion of medicinal plants are 
wild, the correct identification of plant material must be made by literature and consultation 
with experts and herbarium. The lack of scientific identification, or misidentification, will 
compromise the rest of the scientific work on the plant. So, for medicinal plant research, we 
should perform a harvesting for botanical identification and another one for phytochemical 
and pharmacological studies, each one with specific recommendations. From an anatomical 
standpoint, medicinal plants have aroused interest due to their abundance of secretory 
structures such as idioblasts, cavities, channels, laticifers and glandular trichomes, among 
others (Fahn, 1979; Evert, 2006), and the chemical diversity of their secretions which are rich 
in terpenes, alkaloids and phenolic compounds (Harbone, 1997). These secretions can be 
identified by conventional chemical analysis or by histochemical methods, which identify 
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the compounds in situ, such as tests for lipids and terpenic substances, tests for phenolic 
compounds,tests for proteins, tests for alkaloids , tests for carbohydrates and tests for 
crystals. 
3.1 Harvest 
For each medicinal plant there is an appropriate time for harvesting the crop. The 
phytochemical monitoring of the active compounds allows the establishment of the right 
time to harvest. However, for plants whose active principles are not known yet, there are 
some general rules which can be applied. The bark should be harvested in spring, early 
summer and autumn. The humid environment facilitates the detachment of the bark. The 
bark should be carefully removed by cutting vertical segments. Care must be taken not to 
"roulette" the trunk, that is, to remove peels in horizontal cotes surrounding the trunk. This 
procedure prevents the circulation of the sap, resulting in the plant’s death. 
The underground organs: roots, rhizomes, tubers, bulbs of perennial plants should be 
harvested during winter, the dormant period, when the concentration of active principles 
reaches its maximum in these organs. The herbaceous plants and leaves are harvested when 
they start flowering. Some plants allow more than one cut. Sometimes, when there are well 
defined rainy and dry periods, the harvesting of the leaves is done during the dry season, 
allowing the plant to regenerate them during the rainy season. The shoot tips are harvested 
in full bloom and before seed formation. The flowers are cut before opening up completely, 
but sometimes the open inflorescences are harvested. The fruits are harvest "at once", i.e. 
before reaching the mature state. The seeds are harvested when ripe. If they are from fleshy 
fruits, the leftover pulp which surrounds them should be removed and the seeds dried. 
Periods of drought and rainfall influence the content of active principles. Thus, the alkaloid 
content decreases after the rain whereas the content of essential oils increases. The content of 
essential oils decreases after the drought. The concentration of active principles varies 
according to the time of the day. In general, glycosides reach their highest concentration in 
the afternoon, while essential oils reach their maximum level around noon. The exception is 
chamomile (Matricaria recutita), which reaches higher levels and better quality of essential oil 
during the night (Sharapin, 2000). 
3.2 Post-harvest processing  
The post-harvest processing aims at the conservation of the physical, chemical, organoleptic 
and pharmacological characteristics of the plant drug. The inadequate post-harvest 
processing results in low quality raw material, with loss of active ingredients, increased 
microbial load and bad commercial presentation. 
The loss of active ingredients involve: degradation by metabolic processes; active principles 
hydrolysis; decomposition by light; enzymatic decomposition; degradation of thermolabile 
substances by heat ; volatilization of essential oils and contamination by bacteria and fungi. 
The first stage of post-harvest processing involves examination and manual separation of 
parts which are damaged, stained and with signs of attacks by insects and / or fungi. The 
next recommended step, is to wash the drug in running water. 
The most important stage of post-harvest processing is undoubtedly drying. The industry 
uses dried plants, enabling their preservation for prolonged periods of time. The exceptions 
are plants used to obtain essential oils, homeopathic tinctures and some extracts like 
artichoke (Cynara scolymus), which are processed fresh.  
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The moisture content in fresh plants varies from 60% to 80%. The drying process reduces the 
moisture content to 5% - 12%. According to the plant organ, the weight losses during drying 
are: 
- Leaves: 20% to 75% 
- Bark: 40% to 65% 
- Wood: 30% to 70% 
- Roots: 25% to 80% 
- Flowers: 15% to 80% 
The drying process stops the degradation processes caused by yeasts or enzymes, prevents 
the development of microorganisms and oxidation and hydrolysis reactions. However, as it 
involves heat, there are losses of essential oils and volatile substances, as well as the risk of 
degradation of thermolabile substances during the process. Most medicinal plants can be 
dried at temperatures between 30°C and 60°C. Plants containing essential oils or volatile 
substances should be dried at temperatures below 40°C. In all cases good air circulation 
should be ensured, favoring the process. 
The method of drying must be experimentally determined for each plant drug. The slow 
drying may cause harmful changes, by the action of enzymes, fungi and bacteria, before the 
process is completed. A very quick drying hardens the superficial layer of the cells and 
prevents the evaporation of water inside the organ, which also results in the action of 
enzymes (Sharapin, 2000). 
3.2.1 Storage  
However great care has been taken during harvesting and drying, the plants lose active 
ingredients by degradation during storage. Although the recommended time limit for 
storing leaves and shoot tips is from12 to 18 months, and for bark and roots from 12 to 36 
months, some plants lose active ingredients soon. The conservation of vegetable raw 
material for a longer period of time depends on storage conditions. Appropriate conditions 
prevent the product from having contact with the sun, dust, rodents and insects and other 
degradation factors, thereby, impeding the loss of volatile principles. The material can be 
wrapped in burlap sacks or bales. The use of plastic bags should be avoided as it does not 
allow adequate ventilation. The bags should be labeled with the scientific name of the plant 
and the part used entry date, supplier name origin and approval of quality control. 
3.2.2 Grinding 
The grinding is intended to reduce the particle size of the plant drug, making it suitable for 
the next step of the process which is extraction. The extraction of a drug as a whole or 
divided into coarse fragments will be incomplete due to poor penetration of the solvent in 
the plant tissue. It will also be very slow, since the cell membranes act as real barriers 
hindering the extraction procedure. In the case of previously divided drugs, such 
membranes are partially destroyed, making the dissolution of the cellular components in the 
outer liquid easier and more efficient. However, the excessive division and the formation of 
very fine dust may cause problems during the extraction process. In the percolation process 
there is a powder compaction, which impedes the passage of the solvent, resulting in an 
incomplete extraction of the drug. In the maceration process the very fine particles might 
pass to the extract and bring it to a cloudy appearance. The milling process is preceded by 
screening to remove impurities. In this operation strange material, such as large pieces of 
wood, other types of metal are removed manually.  
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4. Microbiological quality control of drug plants and their derivatives  
4.1 Raw material 
The microbiological quality assurance of herbal medicines must necessarily involve a proper 
stance regarding the Good Agricultural Practice. Researchers have even recommended the 
cultivation indoors, with full control over the climate and the presence of pathogens, and the 
possibility of genetic enhancement combined with biotechnological studies, indicating a 
tendency to domestication instead of harvesting from the wild (Calixto, 2000, Blumenthal et 
al., 1998; Bauer & TitteI, 1996). Yet the benefits that the cultivation of medicinal plants may 
bring to the achievement of desirable objectives related to the eight Millennium 
Development Goals proposed by the United Nations (UN) and addressed by the World 
Health Organization (WHO, 2009) (See still missing basic needs - Table 1) indicate the 
strategic importance of these products to the various traditional communities. These 
communities include family farmers, indigenous communities, Maroons, and other 
groupings in a vulnerable socioeconomic position, which have a historical knowledge of the 
properties and use of various medicinal plants, as it has been noted by several academic 
papers focused on the etnopharmacy (Pieroni & Vandebroek, 2007; Yoney et al., 2010; 
Leonti, 2011).For the success of this strategy it is necessary to ensure these communities with 
the access to this information and know-how, since they supply raw materials. This 
connection apparently seems to be unattainable due to social, anthropological and cultural 
incompatibilities. But what we have observed in practice is the gradual development of 
market relations between the major urban centers and the more reserved communities, 
which generally seek to avoid contact with the outside elements. This fact demonstrates the 
tendency of many of these communities to open channels for knowledge and values 
exchange in order to facilitate the development and quality of life without their identity loss. 
4.2 Regulatory aspects 
Heterogeneity exists not only between countries but even within the same country in 
relation to the maximum microbial limits which are acceptable for herbal products. 
Moreover, the treatment or application of plant material also involves different microbial 
limits and surveillance strictness. In some countries, herbal drugs for oral, topical or 
episodic use, produced by infusions, decoctions and maceration, have different laws when 
compared to plant drugs presented as capsules, tinctures, tablets, extracts and syrups. 
However, in general, the tests used to verify the presence of microorganisms in plant drugs 
show no significant variation and follow the recommendations used for non-sterile 
pharmaceutical products (Table 1). 
4.3 Tests 
4.3.1 Sampling and sample preparation  
Initially 10 ml or 10 g of sample are needed for the performance of the assays. In case of raw 
materials, an interesting strategy to homogenize the sample and facilitate the interaction 
with the culture medium used, is the previous hand-grinding with a properly sterilized 
mortar and pestle in a sterile environment such as a laminar flow biological safety cabinet. 
So, when our analysis objects are leaves, stems or other plant constituents in their raw state, 
the sample preparation becomes important. On the other hand, thinner powders interact 
well with the solutions used in the homogenization and in the adjustment to near-neutral 
pH (pH = 7.0), favoring the growth of microorganisms present in the sample. Therefore, the 
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pharmaceutical form may provide different strategies for sample preparation. In some cases 
it may be necessary to use other previous procedures, such as the use of inactivating agents, 
if evidenced the presence of preservatives in cosmetics based on herbal medicines, for 
example. When there is doubt about the presence of substances with inhibitory microbial 
growth a preparatory test for assessing the inhibitory capacity can be used. Carry out a 
transfer of each of the viable strains of Staphylococcus aureus, Pseudomonas aeruginosa, 
Salmonella, Escherichia coli and Candida albicans to 5 ml of soyabean casein broth and incubate 
at 30°C-35°C for 24 hours for bacteria and at 20°C- 25°C for 24 hours in the case of Candida 
albicans, making decimal dilutions in buffered peptone solution to obtain a suspension 
containing 50 to 100 viable cells. Use 1 ml of the microorganisms’ inoculum separately in the 
presence or absence of the sample and incubate again as described for bacteria and fungi. If 
there is massive growth of microorganisms, microbiological assays may be undertaken; in 
case of little or no growth of viable strains it is necessary to use inactivating agents, for 
example, 0.5% soy lecithin, 4% polysorbate 20, 0.1% polysorbate 80, among others. 
 
 
Table 1. Recommended microbial limits for herbal drugs and their products or botanical 
ingredients and products 
4.3.2 Viable microorganisms count 
After preliminary tests, pour 10 ml or 10 g sample into a container containing 90 ml of 
soyabean casein broth, nutrient broth, buffered peptone broth or other appropriate diluents. 
It is important to attempt to the fact that the pH should be near-neutral and the 
characteristics of the sample, such as raw materials from forest origin, may contain higher 
amounts of fungi and therefore prone to high levels of aflatoxins. So, an appropriate 
medium would be one that favors the growth of fungi capable of producing these 
substances. From this first dilution, transfer 1 ml to tubes containing 9 ml of the used 
diluent, for example, soyabean casein broth, so as to obtain serial dilutions of 10-1, 10-2 and 
10-3. In some cases the number of dilutions can be increased to improve the counting (Figure 
1). From each dilution, transfer volumes of 0.1 to 0.5 ml to Petri dishes in duplicate 
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containing Soyabean Casein Agar or Sabouraud-Dextrose Agar for counting bacteria and 
fungi, respectively. The spreading is accomplished with the aid of Drigalski spatula or a 
sterile glass rod. In case of bacteria, the incubation should be at 30°C-35 °C for 48 to 72 
hours; for fungi, temperatures from 20°C to 25 °C for 5-7 days at least. Antibiotics are 
commonly used in the culture medium in order to inhibit the growth of undesirable 
microorganisms. Therefore, amphotericin B is added to the culture medium for bacterial 
growth (Soyabean Casein Agar or Nutrient Agar) and chloramphenicol to the culture 
medium for fungi growth (Sabouraud-Dextrose Agar or Potato Agar). 
 
 
Fig. 1. Viable microorganism count 
4.3.3 Search for undesirable microorganisms  
Using appropriate enrichment medium, the same amount of sample used for the 
enumeration of microorganisms (10ml or 10 g of sample in a container containing 90 ml of 
medium) is used for the detection of pathogens. For detection of Escherichia coli and 
Salmonella sp., lactose broth is used and for the latter, after enrichment in lactose broth, the 
procedure is incubation in tetrathionate broth or selenite cystine broth for 24 hours at 30°C - 
35 °C. In the case of Staphylococcus aureus and Pseudomonas aeruginosa, soybean casein broth 
is used for enrichment, which should also occur for 24 hours at 30°C - 35 ° C. Then, aliquots 
are transferred to culture medium for isolation and differentiation and subsequent use for 
conventional biochemical assessments (Figure 2 and 3). 
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Fig. 2. Enrichment and selective medium to S. aureus and P. aeruginosa 
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Fig. 3. Enrichment and selective medium to E. coli and Salmonella 
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5. Physical, chemical and physico-chemical controls of quality of herbal 
drugs and/or their derivatives: Tinctures and extracts 
To ensure quality for vegetable raw material, the WHO, 1992 recommends that the 
pharmacopoeia specifications for the plant material must include: 
- Botanical name, with reference to the authors; 
- Specification of the part used; 
- Morphological description, macro and microscopic examination; 
- Determination of particle size distribution; 
- Determination of total ash or sulfated ash (residue on ignition) and acid insoluble ash; 
- Determination of extractable matter; 
- Determination of water and loss on drying; 
- Determination of essential oils; 
- Identification by thin layer chromatography; 
- Quantitative determination of active constituents; 
- Limit tests for heavy metals; 
- Determination of pesticide residues. 
5.1 Botanical name 
The botanical identification is essential to characterize the plant species. This identification 
cannot be made through popular names since the same species may have different common 
names and different species may be designated by the same common name. The 
identification of the plant is given by its "scientific name". The scientific name is always a 
Latin binomial, a term identifying the gender and both of them together identifying the 
species. The Latin binomial is followed by the name of the author of the botanical 
description, usually abbreviated. Finally, the identification is completed with the name of 
the botanical family to which the plant belongs. 
5.2 Specification of the used part  
The drug, i.e., used part of the plant, must be specified, for example, inflorescence, leaves, 
roots, wood or seeds. The specification is described in the language of the country and in 
Latin. The European Pharmacopoeia adopts as the title of the drug monograph, its name in 
Latin and as the subtitle, its name in English (or French, depending on the edition). The 
Brazilian Pharmacopoeia adopts as a title the popular name of the plant and as the subtitle, 
the specification of the used part, in Latin. Both pharmacopoeias complete the identification 
with the botanical name of the plant and specifications related to the content of active 
principles. The European Pharmacopoeia includes the scientific name of the plant when 
describing the drug, while the Brazilian Pharmacopoeia emphasizes it before the description. 
5.3 Morphological description, macro and microscopic examination  
A monograph of a plant drug describes the macroscopic, microscopic and organoleptic 
characteristics. The characteristics described should be compared to the drug sample, as a 
first step to establish its identity and purity. Whenever possible, authentic samples of the 
drug should be used as reference samples. The organoleptic characteristics (odor and flavor) 
often represent a practical guidance regarding the identity and purity of the drug. If the 
odor and taste vary considerably from the drug prescribed, the drug may be considered out 
of specification. 
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The macroscopic characteristics include the shape, size, color, texture, fracture aspects and 
characteristics of the cut surface. These features are useful for determining the identity and 
purity of the drug in question. However, since the judgment of these characteristics is very 
subjective, comparisons to authentic samples should be taken to avoid doubts. 
The microscopic characteristics are viewed under a microscope, with or without the 
addition of chemical reagents. Microscopic analysis is indispensable for powdered drugs. 
This analysis helps to identify the drug and may be crucial in the identification of 
adulterants. However to ensure the identification of the drug, the microscopic analysis 
should be supplemented with data from chemical and physico-chemical analysis, Figures 4 
and 5 (Alves, 2008; Alves et al. 2010). 
 
 
Fig. 4. Arrabidaea chica (Humb. & Bonpl.) B. Verlt. (Bignoniaceae). Cross section of the 
petiole. Detail of the vascular system and sclerenchyma; external phloem; xylem; internal 
phloem; sclerenchyma; parenchyma cells 
 
 
Fig. 5. Arrabidaea chica (Humb. & Bonpl.) B. Verlt. (Bignoniaceae). Cross section of the basal 
lamina. Upper epidermis; lower epidermis; angular collenchyma; fundamental parenchyma; 
sclerenchyma; phloem; xylem; palisade parenchyma e cuticule 
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5.4 Determination of particle size distribution 
The particle size distribution of herbal drugs determines the contact surface available for 
interaction with the solvent used to obtain the plant derivative. It is a preliminary and 
important parameter for choosing the appropriate extraction process, as it has a direct 
influence on its efficiency (Santos et al., 2000). 
Procedure for determination of particle size distribution: an electromagnetic sieve shaker is 
used. About 10 g of powdered plant material are subjected to a series of sieves with mesh 
size opening ranging from 2.00 mm to 125 µm, and agitated for 30 minutes. The particle size 
is analyzed in triplicate and evaluated by quantifying the percentage of powder retention in 
each sieve (Brazilian Pharmacopoeia V, 2010) 
5.5 Determination of ash  
The determination of ash includes the determination of total ash, sulfated ash, also called 
residue on ignition and determination of acid-insoluble ash. The total ash involves 
determining both the physiological and the non-physiological ash and consists of measuring 
the amount of non volatilized residue after the drug calcination. Sulfated ash is represented 
by non volatilized residue after calcination with concentrated sulfuric acid. The metals 
contained in the drug are converted to sulfates, as these are more stable to heat, and allow 
more accurate results than those obtained by simple calcination. The acid-insoluble ash is 
the residue obtained after boiling the residue obtained in the determination of total ash and 
sulfated ash with dilute hydrochloric acid, filtrating to remove the soluble and igniting the 
remaining insoluble matter. This procedure determines the level of silica, especially sand 
and siliceous earth present in the drug.  
Procedure for determination of total ash: Accurately 3 grams of the powder is transferred to 
porcelain crucibles which were previously calcined, cooled and weighed. The samples are 
charred in a muffle furnace at 450 ºC for 2 hours. After cooling in a desiccator, they are 
weighed on an analytical balance. This procedure is repeated until obtaining constant 
weight. The ash percentage obtained in triplicate, is calculated in relation to the dried drug 
(Brazilian Pharmacopoeia V, 2010). 
5.6 Determination of extractable matter  
The determination of extractable matter is carried out when there are no suitable methods to 
determine the active constituents of the drug by chemical or physico –chemical processes. 
Substances extracted with water, with ethanol in various dilutions and, more rarely, with 
ether are usually determined. The method is based on the solubility of active substances in a 
given solvent, and when these are not known, on the pharmacological activity of the extract 
obtained as a solvent. 
5.7 Determination of water and loss on drying 
The presence of excessive amounts of water in plant drugs is responsible for the growth of 
bacteria and fungi as well as the hydrolysis of constituents. The pharmacopoeial 
monographs limit the water content, especially in drugs that have the facility to absorb it, or 
in which the excessive amounts of water cause deterioration. With few exceptions, the water 
content in vegetable drugs should vary between 8% and 14%. 
The water content can be determined by the gravimetric method, where the drug is 
desiccated to constant weight in an oven. The heating also causes the loss of volatile 
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substances. For this reason it cannot be applied to drugs that contain such substances. In this 
case the azeotropic method may be applied, which consists of distilling the drug sample 
with toluene or xylene. This method requires special equipment and it is more difficult to 
carry on than the gravimetric method. 
Procedure for determination of water loss on drying and gravimetric method: Exactly 3 
grams of powdered plant are transferred to a weighing bottle. The sample is subjected to a 
temperature of 105° C for two hours followed by cooling in desiccators and weighted 
(Costa, 1982; Brazilian Pharmacopoeia V, 2010). The operation is repeated until obtaining 
constant weight. The results of three determinations are evaluated in terms of weight 
percentage on the sample amount using the equation (Brazilian Pharmacopoeia V, 2010): 
 
Wb-Wa
% loss 100
Ws
= ×  (1) 
Where: 
Ws = sample weight (g) 
Wb = weight of the weighing bottle containing the sample before drying (g) 
Wa = weight of the weighing bottle containing the sample after drying (g) 
Another method that can be applied is the Karl Fischer Method, which is based on the 
quantitative reaction between water and anhydrous solution of iodine and sulfur dioxide 
dissolved in pyridine and methanol (Karl Fischer reagents). Usually the excess of reagent is 
incorporated to the sample, and after waiting for the time required to the quantitative 
reaction, the reagent excess is titrated with a standard solution of water in methanol. This 
technique (of unrestricted use) is especially recommended for samples which slowly release 
their content in water. 
5.8 Determination of essential oils 
Essential oils are volatile constituents found in many plants and characterized the mixture of 
terpenes, sesquiterpenes and their oxygenated derivatives and, sometimes, aromatic 
compounds, which volatilize at room temperature and are oily. Essential oils usually 
contain pharmacologically active substances. The determination of essential oils is carried 
out by hydrodistillation collecting the distillate in a graduated tube, in which the aqueous 
phase is automatically separated from the oily phase and returns to the distillation flask. 
When the essential oil has a density near to that of water or when the phase separation is 
difficult, a previously measured quantity of a solvent with low mass density and a suitable 
boiling point (e.g. xylene) is added in the graduated tube to dissolve the essential oil and 
facilitate the separation. 
5.9 Identification by thin layer chromatography  
The TLC is a simple, efficient method and requires no sophisticated devices for its 
implementation. The method is used for the characterization of plant drugs, their extracts 
and tinctures, and indicates the presence of the drug or its extracts in a pharmaceutical 
formulation. When the active principles of the drug are not known, the identification should 
be made using the substances which are characteristics of the plant, even without 
pharmacological activity. 
These substances, called markers (or positive markers), should be selected among the 
substances that are characteristic of the plant. Its use, however, should be limited to the 
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identification of plant material, extracts and tinctures. The markers may also serve to 
identify the presence of the drug in a pharmaceutical formulation. However, when the 
markers are not the substances responsible for the pharmacological action of the drug they 
cannot be used for quantitative measurements. The existence of stained spots or bands with 
the same Rf of the reference substances, in the chromatogram of the sample is not sufficient 
to identify the drug. 
The existence of other stained spots or bands and their position in relation to the position of 
the reference substances used must also be described. The use of reference substances that 
are not the plant constituents is useful in determining the occurrence of counterfeits. These 
substances are called negative markers. So, Arnica montana extracts are analyzed by 
comparison with rutin solutions, a substance that does not occur in this plant. The 
appearance of a spot in the chromatogram of the extract with the same Rf and color of rutin 
indicates a possible forgery with Calendula officinalis flowers. 
 
 
Fig. 6. TLC analysis of the tincture of Calendula officinalis L. Eluent I: ethyl acetate; formic 
acid; acetic acid; water (100:11:11:26); developer: NP/PEG 4000. Observation under light UV 
365 nm; P- rutin standard ; T- Calendula tincture (Nunes, 2008; Nunes et al., 2009) 
5.10 Quantitative determination of active principles  
The selection of a method for quantitative determination of active principles in 
phytotherapeutics depends on the monograph of the drug in matter, which must to be 
considered as a whole designed to assure a satisfactory quality to the product. Many times 
the selection of a quantification method falls on a less specific technique, which despite the 
ease in performing, shows high precision, as for example, the acid-base volumetric 
determination of alkaloids, or titration in non aqueous solutions. If analytical equipments 
are available, among other more elaborated methods, the ultraviolet spectroscopy, a fast and 
simple technique with relative low cost, can be employed to quantify markers which present 
at least a chromophore, a functional group that absorbs light between 200nm 400nm. 
However, some molecules do not present such group and in this case it is worth, to 
introduce a chromophore in the molecule or to adopt another quantification technique. 
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Sometime it is not possible to isolate or get the marker in adequate conditions to be used in 
the method, and it is possible to characterize and quantify a group of substances of the same 
metabolic class to which the pharmacological activity of the plant can be associated. This is 
the case of the alkaloids of a species from Himatanthus genus, to which antispasmodic 
activity is alleged, and that were characterized and quantified as total alkaloid fraction in 
relation to the yoimbine (Barros, 2010). The method was developed in laboratory and 
validated according to both Brazilian and International regulation (ANVISA, 2003; IHC, 
2005), taking into account the following parameters: selectivity, verified by analysis of the 
reference substance in comparison with the sample and their solvent (Methanol), in the 
same wavelength, where the absorption of the sample and the substance and the transparency 
of the solvent can be observed; the linearity, characterized by the determination (R2) and 
correlation (r) coefficients of the reference substance, and also, by the statistical analysis of 
the residue of the concentration values used to evaluate this parameter. Using five from the 
seven yoimbine concentration values employed to determine the linearity of the method, a 
calibration curve was built to, in fact, quantify the marker in the sample. The repeatability, 
the intermediate precision and the accuracy of the method must also be verified. In Brazil, 
ANVISA determines a 5% limit to the variation of the accuracy of a quantification method, 
which should not be lower than 95%. Other parameters that validate the developed method 
are detection and quantification limits. The following figures illustrate the selectivity (Figure 
7), the linearity (Figure 8) e the analysis of residue (Figure 9) extracted from Himatanthus sp. 
(Barros, 2010). 
Currently, in Brazil the regulation agency recommends for the registration of 
phytotherapeutical the use of more elaborated methods, which demand techniques like 
High Performance Liquid Chromatogrphy (HPLC) or Gas Chromatography (GC), for the 
quantification of markers. 
 
0.6
0.4
0.2
0.0
A
b
s
Methanol
250                         300                         350                         400
                   Wavelength (nm)
281
 
Fig. 7. Selectivity of the method developed with 22µg/mL Yoimbine as reference, (- - -), in 
relation to the alkaloid fraction of the aqueous extract of Himatanthus sp at 30 µg/mL (-) 
and to solvent methanol, observed from 200nm to 400nm (absorbance vs wavelength) 
5.11 Limit tests for heavy metals 
The limit test for heavy metals consists in verifying if the content of metallic impurities that 
react colorimetrically with sulfide ion does not exceed the limit specified in the monographs 
in terms of micrograms of lead per gram of test sample. Similarly, the reaction with 
thioacetamide may be employed for determining the limit of heavy metals in terms of lead. 
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Fig. 8. Graphical representation of the linearity of the method using Yoimbine in methanol 
at 281nm, the detail concentrations and its respective absorbance (absorbance vs 
concentration) 
 
 
Fig. 9. Graphical representation of the residues analysis of the concentration values of 
Yoimbine solutions at 16, 18, 20, 22, 24, 26 and 28 µg/mL used in the calibration curve and 
determination of linearity 
Procedure: The tests are conducted in transparent flat-bottomed glass tubes, with a capacity 
of approximately 70 mL and the external mark corresponding to a volume of 45-50 mL with 
an internal diameter of 23 mm. The tubes used should be equal in both the inner diameter 
and in other aspects, since the comparison is direct. The tubes should be observed from 
above, against a white background. The standard volume used varies according to the 
specified in the monograph under analysis. 
μg/mL Abs. 
16 0,335
18 0,363
20 0,413
22 0,429
24 0,471
26 0,513
28 0,559
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5.12 Determination of pesticide residues 
The use of pesticides to protect growing plants used as food from destruction by insects has 
grown enormously. The perception of the serious danger that the indiscriminate use of 
pesticides represented has led the WHO to establish limits to their residues. Since then, 
numerous methods for pesticide residue analysis have been published in the literature. 
Medicinal plants as well as food plants are subjected to attack by insects and fungi. Weeds 
are responsible for the reduced yields. Plant drugs accumulate pesticide just as food plants 
from agricultural practices such as spray application, the capture of the treated soils or 
administration of fumigants during storage. 
6. Other methods that can be used for quality control of herbal drugs and/or 
their derivatives, tinctures and extracts  
6.1 The infrared (IR) and ultaviolet (UV) spectroscopy 
 Infrared radiation corresponds approximately to the portion of the electromagnetic 
spectrum lying between the regions of the visible and microwave. The most useful portion 
to organic chemistry is situated between 4000 cm-1 and 400 cm-1. This band when absorbed 
by an organic molecule, converts into a molecular vibration energy. The process is quantized, 
like a series of bands, as each change of vibrational energy level corresponds to a series of 
changes in rotational energy levels (Silverstein et al., 2007). It is possible to obtain spectra of 
gases, liquids and solids in the infrared. Liquids can be examined in their pure state or in 
solution. The solvent should be fairly transparent in the region of interest so as not to 
interfere in the result. Volatile liquids are examined in closed cells with very thin spacers. 
Solid samples are examined in the form of airborne dust, pressed disk (KBr, ZnSe, etc.), or 
glassy film deposited on a transparent plate (Silverstein et al., 2007). 
The infrared spectrum of a chemical compound is considered one of its most characteristic 
physic-chemical features and, because of this the infrared spectroscopy is extensively used 
to indentify compounds (Silverstein et al., 2007). 
Another type of spectroscopy is performed in the ultraviolet (UV) region involving photons 
spectroscopy, and called spectrophotometry. Using a range between 200 to 400 nm the 
molecules undergo electronic transitions of molecular orbitals (Silverstein et al., 2007) 
The UV spectrophotometry is one of the most used methods in analytical determinations in 
various fields and may be applied to determinations of organic and inorganic compounds, for 
example, in the identification of the active principle of the drug. The molecular absorption 
spectroscopy is valuable for the identification of functional groups in the molecule. More 
important, however, are the applications of ultraviolet absorption spectroscopy for the 
quantitative determination of compounds containing chromophoric groups (Vinade & Vinade, 
2005). Spectrophotometry in the UV region of the electromagnetic spectrum is one of the most 
used analytical techniques in terms of robustness, relatively low cost and large number of 
developed applications. It is based on the Beer-Lambert law, which is the mathematical basis 
for measuring radiation absorption by samples in solid, liquid or gaseous state in ultraviolet 
regions, visible and infrared electromagnetic spectrum (Perkampus, 1992). In determining the 
parameters of quality control of herbal medicines, which are composed of a complex mixture 
of components and due to the limitations on sensitivity in this method it is often necessary to 
use preliminary steps for separation and concentration of the desired elements, with a 
consequent increase of sensitivity. Among these techniques, we can mention the liquid-liquid 
extraction, precipitation and solid-liquid extraction (Cheng and Bray, 1955). 
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6.2 Thermal analysis 
Thermal analysis is a term used to describe the analytical techniques that measure the 
physical and chemical properties of a sample as a function of temperature, while the 
substance is subjected to a controlled temperature program. The sample is subjected to a 
temperature schedule that consists of a series of preselected segments in which the sample is 
heated or cooled at a constant rate or kept at a constant temperature (Giolito & Ionashiro, 
1988). 
In recent decades, the thermo analytical techniques have gained increasing importance in all 
areas of knowledge in basic and applied chemistry. This development in the use of this 
methodology really endowed with great potential, was favored by the availability of 
instruments controlled by microprocessors, capable of providing accurate information about 
the thermal behavior of materials in a relatively short time. These methods are widely used 
in quality control of natural and synthetic drugs, because they can quickly provide data on 
the stability of the analyzed material, in the presence of its thermal behavior (Giolito & 
Ionashiro, 1988). Other methodologies which are importantly increasing in Brazil are: 
thermogravimetry (TG), differential thermal analysis (DTA) and differential scanning 
calorimetry (DSC) which are used to study pre-formulation or drug excipient compatibility. 
Among several papers published in this area, the most outstanding ones are: application of 
thermogravimetry (TG) in quality control of Milon (Cissampelos sympodialis Eichi.) 
Minispermaceae (Aragão et al., 2002), thermal analysis and compatibility study of 
zidovudine with excipients (Araujo et al., 2003); study of thermal stability of metronidazole 
tablets (Souza et al., 2002); Thermal analysis study of captopril coated tablets by 
thermogravimetry (TG) and differential scanning calorimetry (DSC) (Bazzo & SILVA, 2005); 
thermoanalytical study of glibenclamide and excipients (Oliveira et al., 2004); 
thermoanalitycal study (TG, DTG and DSC) of in natura and processed coffee (Schnitzler et 
al., 2005); study, characterization and determination of the purity of commercial samples of 
saccharin (Schnitzler et al., 2005); determination of moisture content and ash content of 
commercial samples of guarana using conventional methods and thermal analysis 
(ARAÚJO et al., 2006); physicochemical characterization of fluid and spray dried extracts of 
Symphytum officinale L. (Silva Júnior, 2006; Silva Júnior et al., 2006), assessing the 
compatibility between fluoxetine and excipients used in the manufacture of capsules (Stulz 
& Tagliari, 2006); thermoanalytical study and drug-excipient compatibility of rifampicin and 
some medications used in the treatment of Tuberculosis (Alves, 2007), thermal stability and 
compatibility of hydroquinone (Tagliari et al., 2008). 
7. Conclusion 
The development of herbal medicines, as a rule, involves planning and obtaining 
intermediate preparations as required steps for processing vegetable raw material into a 
finished product, which will provide the desired pharmaceutical presentation. Among the 
available intermediate preparations, Pharmacopoeias recommend the tincture or fluid 
extract. These liquid presentations can be utilized to obtain standardized dried extracts, 
which can be used in the production of various pharmaceutical forms. It is important that 
the starting material is stabilized in order to ensure the reproducibility of the process. It also 
has to be sufficiently pulverized so as to achieve optimum performance in the process of 
extracting the chemical constituents of pharmaceutical interest. 
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To obtain a derivative of any medicinal plant, being it herbal medicine in any form, quality 
control is required from the cultivation, management and harvesting of the plant species; 
passing through the production of intermediate product up to the final formulation. 
Following a set of criteria it is possible to characterize the raw plant, its derivative and the 
formulation, designating an adequate planning to be followed as to establish the parameters 
of quality control. When the approach is applied to the analysis of natural extracts, the study 
of pre-formulation becomes more difficult because often the available markers are altered as 
a function of pH, solvent polarity, temperature and interactions (excipient and vehicle). 
When formulating products containing natural ingredients it is essential to identify 
standardized markers or to develop methods for the quantification of purified chemical 
groups before, during and after the production process. Therefore, for the technological 
development of herbal medicines according to the requirements and specifications of the 
countries’ laws, it is essential to establish protocols that ensure quality control of raw 
materials, vegetable products and ingredients used in their production, as well as validation 
of qualitative and quantitative techniques appropriate to the chemical markers chosen. Only 
then, we can get a finished product with assured quality. 
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